For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
DelveInsight's "Age-related Macular Degeneration (AMD) - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Age-related Macular Degeneration (AMD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.
Markets Covered
- United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2016-2028
Age-related Macular Degeneration (AMD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Age-related Macular Degeneration (AMD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Age-related Macular Degeneration (AMD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Age-related Macular Degeneration (AMD) scenario.
Age-related Macular Degeneration (AMD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Age-related Macular Degeneration (AMD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.
Report Scope
- The report covers detailed overview of Age-related Macular Degeneration (AMD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
- The Age-related Macular Degeneration (AMD) Report assesses the disease risk and burden and highlights the unmet needs
- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population
Key strengths
- 10 Year Forecast
- 7MM Coverage
- Total Cases in Age-related Macular Degeneration (AMD)
Key assessments
- Patient Segmentation in Age-related Macular Degeneration (AMD)
- Age-related Macular Degeneration (AMD) Risk & Burden
- Factors driving growth in a specific Age-related Macular Degeneration (AMD) patient population